Search

Your search keyword '"Evan Fletcher"' showing total 70 results

Search Constraints

Start Over You searched for: Author "Evan Fletcher" Remove constraint Author: "Evan Fletcher" Topic cellular and molecular neuroscience Remove constraint Topic: cellular and molecular neuroscience
70 results on '"Evan Fletcher"'

Search Results

1. Cardiovascular health and resilience to cognitive decline and impairment among diverse Hispanics/Latinos: Results from the Study of Latinos‐ Investigation of Neurocognitive Aging (SOL‐INCA)

2. Reducing MRI Inter‐Scanner Variability Using 3D Superpixel ComBat

3. Associations of Amyloid, White Matter Hyperintensities, and Hippocampal Volume with Cognitive Trajectories in the Oldest‐Old: The 90+ Study

5. Association of plasma abeta and tau levels in relation to cognition and brain structure in a diverse community

7. Self‐reported sleep duration is not associated with pet amyloid deposition in the oldest‐old: The 90+ Study

8. Structural brain network efficiency and cognitive processing speed in healthy aging

9. Towards a generalized deep learning framework for production scale segmentation of brain structures

10. Prediction and Classification of Alzheimer’s Disease Based on Combined Features From Apolipoprotein-E Genotype, Cerebrospinal Fluid, MR, and FDG-PET Imaging Biomarkers

11. IC‐P‐127: CEREBRAL TRACT INTEGRITY RELATES TO WHITE MATTER HYPERINTENSITIES, CORTEX VOLUME, AND COGNITION

12. P3‐431: CEREBRAL WHITE MATTER FREE WATER: A SENSITIVE BIOMARKER OF COGNITION AND FUNCTION

13. P1‐443: ASSOCIATION BETWEEN REGIONAL AMYLOID AND REGIONAL TAU IN YOUNGER, NON‐DEMENTED INDIVIDUALS IN THE FRAMINGHAM HEART STUDY

14. IC‐P‐138: ASSOCIATION BETWEEN REGIONAL AMYLOID AND REGIONAL TAU WITHIN YOUNGER, NON‐DEMENTED INDIVIDUALS OF THE FRAMINGHAM HEART STUDY

15. P2‐245: ENDOTHELIAL‐DERIVED EXOSOME BIOMARKERS SUGGEST ACTIVATION OF INNATE IMMUNITY IN SUBCLINICAL CEREBROVASCULAR DISEASE

17. P2‐387: CEREBRAL TRACT INTEGRITY RELATES TO WHITE MATTER HYPERINTENSITIES, CORTEX VOLUME, AND COGNITION

18. P3‐367: PET AMYLOID IMAGING WITH FLORBETAPIR AND COGNITION IN THE OLDEST‐OLD: THE 90+ STUDY

19. O2‐13‐04: WHITE MATTER HYPERINTENSITIES AND CSF BIOMARKERS IN RELATION TO CLINICAL SYMPTOM ONSET IN PRECLINICAL ALZHEIMER'S DISEASE

21. P1-417: DEEP LEARNING FOR PRODUCTION SCALE BRAIN EXTRACTION IN MRI: RESULTS BASED ON LARGE DATASET TRAINING

22. P3-345: BRAIN STRUCTURAL NETWORK EFFICIENCY IS ASSOCIATED WITH A HIERARCHY OF GRAY MATTER REGIONS: RESULTS FROM THE FRAMINGHAM HEART STUDY

23. P2-420: CAUDATE NUCLEUS VOLUMES RELATE TO PROCESSING SPEED IN HEALTHY ADULTS: RESULTS FROM THE FRAMINGHAM HEART STUDY

24. P3-352: ASSOCIATION BETWEEN COGNITION AND CEREBRAL WHITE MATTER FREE WATER IN ADULTS FROM THE FRAMINGHAM HEART STUDY: A DIFFUSION TENSOR IMAGING VOXEL-BASED STUDY

25. IC-P-087: ASSOCIATION BETWEEN COGNITION AND CEREBRAL WHITE MATTER FREE WATER IN ADULTS FROM THE FRAMINGHAM HEART STUDY: A DIFFUSION TENSOR IMAGING VOXEL-BASED STUDY

27. P3-430: THE RELATION BETWEEN AMYLOID IMAGING AND AMYLOID PATHOLOGY IN THE OLDEST OLD: THE 90+ STUDY

28. [P4–518]: THALAMIC VOLUME LOSS AFTER STROKE ACCELERATED BY WHITE MATTER HYPERINTENSITY LESION LOAD IPSILESIONALLY

29. [P4–199]: THE ASSOCIATION BETWEEN AMYLOID IMAGING AND COGNITION IN THE OLDEST‐OLD WITHOUT DEMENTIA

30. [O2–10–01]: HIGHER EDUCATION CONFERS RESILIENCE IN THE OLDEST‐OLD WITH POSITIVE AMYLOID PET SCAN

32. [P3–421]: STAGING OF AMYLOID‐β, TAU, REGIONAL ATROPHY RATES AND COGNITIVE CHANGE IN A NON‐DEMENTED COHORT

33. [P4–519]: LONGITUDINAL HIPPOCAMPAL VOLUME CHANGE DEMONSTRATED USING BOTH MANUAL AND AUTOMATED METHODS IN ISCHAEMIC STROKE POPULATIONS

34. P3-348: REDUCED STRUCTURAL BRAIN NETWORK MODULARITY IN HEALTHY AGING: RESULTS FROM THE FRAMINGHAM HEART STUDY

35. O3-04-03: MRI MEASURES OF NEURODEGENERATION AND VASCULAR INJURY, BUT NOT AMYLOID STATUS, PREDICT COGNITIVE DECLINE IN NORMAL INDIVIDUALS FOLLOWED FOR 7 YEARS ON AVERAGE

36. O1‐12‐06: Effects of Baseline Amyloid‐b and Hippocampal Volume on Brain Atrophy Rates and Cognition in a Non‐Demented Cohort

37. P1‐267: Amyloid Burden Does Not Differentiate Cognitive Status Amongst The Oldest Old: The 90+ Study

38. F1‐01‐04: Ethnic/racial differences in brain mechanisms of cognitive decline

39. Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2

41. P3‐199: BRAIN STRUCTURAL COVARIANCE IN MIDLIFE: THE FRAMINGHAM OFFSPRING STUDY

42. IC‐P‐132: BASELINE WHITE MATTER HYPERINTENSITIES AND GRAY MATTER VOLUME INDEPENDENTLY PREDICT COGNITIVE TRAJECTORIES IN ADNI II

43. P1‐148: IN COGNITIVELY HEALTHY ELDERLY, FORNIX MICROSTRUCTURE BUT NOT MEDIAL TEMPORAL GRAY MATTER PREDICTS BRAIN ATROPHY IN CIRCUITS AFFECTED BY ALZHEIMER'S DISEASE

45. IC‐01‐04: VASCULAR RISK FACTORS IMPACT COGNITION INDEPENDENT OF PIB PET AND MRI MEASURES OF AD AND VASCULAR BRAIN INJURY

47. IC‐P‐183: Reproducibility of intracranial and hippocampal volume quantification at 1.5T and 3T MRI: Application to ADNI I

48. P2–148: Longitudinal hippocampal atrophy is associated with hippocampus functional connectivity changes in cognitively normal elders

49. P3–128: Fornix white matter degeneration is a sensitive indicator of both early and late cognitive decline in a diverse community cohort

50. P1–313: Reproducibility of intracranial and hippocampal volume quantification at 1.5T and 3T MRI: Application to ADNI I

Catalog

Books, media, physical & digital resources